Company profile for Hemogenyx Pharmaceuticals

Hemogenyx Pharmaceuticals

NEW Drugs in Dev: 2

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

Contact Supplier

Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

pharmacompass-2-m-2026-04-20

Contact Supplier

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

74 News #PharmaBuzz

media
74 News #PharmaBuzz

DEVELOPMENTS

17 Drugs in Development

17 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Hemogenyx Pharmaceuticals plc is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located at its state-of-the-art research facility in New York City and a Belgian subsidiary, Hemogenyx-Cell SPRL, located in Liège. For more than 50 years, bone marrow transplantation has been used to save the lives of patients suffering from bl...

Hemogenyx Pharmaceuticals plc is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located at its state-of-the-art research facility in New York City and a Belgian subsidiary, Hemogenyx-Cell SPRL, located in Liège. For more than 50 years, bone marrow transplantation has been used to save the lives of patients suffering from blood diseases. The risks of toxicity and death that are associated with bone marrow transplantation, however, have meant that the procedure is restricted to use only as a last resort.

PEGS Boston SummitPEGS Boston Summit

Not Confirmed

Not Confirmed

11 May-15 November, 2026

Massachusetts, U.S.A
DIA Global Annual Meet...DIA Global Annual Meeting

Not Confirmed

Not Confirmed

14-18 June, 2026

Philadelphia, U.S.A
Discovery EuropeDiscovery Europe

Not Confirmed

Not Confirmed

15-16 June, 2026

Berlin, Germany

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

unitedkingdom_new Flag

Country

Country

United Kingdom

Address

Address

5 Fleet Place, London, EC4M 7RD

Telephone

Telephone

Email

enquiries@pharmacompass.com

Client Website

Website

https://hemogenyx.com/

Linkedin

youtube

YouTube

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Hemogenyx Pharmaceuticals Announces Annual General Meeting Notice

05 Jun 2026

// ACCESSWIRE

Hemogenyx Pharma Grants Options, Extends Warrant Terms

29 May 2026

// PHARMIWEB

Hemogenyx Pharmaceuticals PLC Announces Final Results

30 Apr 2026

// PHARMIWEB

Hemogenyx Pharmaceuticals PLC Announces Institutional Fundraise

28 Apr 2026

// PHARMIWEB

Hemogenyx Pharma Reports Annual IND To FDA

14 Apr 2026

// PHARMIWEB

Hemogenyx Completes Tech Transfer and Updates on Clinical Trial

31 Mar 2026

// PHARMIWEB

Drugs in Development

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Market Place

Home

Menu

Post Enquiry

Market Place

Search